Crohn's disease and growth deficiency in children and adolescents

World Journal of Gastroenterology

Volumn 20, Issue 37, 2014, Pages 13219-13233

  Gasparetto, Marco ^a   Guariso, Graziella ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Bone health; Enteral nutrition; Growth; Height; Linear growth; Pediatric Crohn's disease; Pediatric inflammatory bowel disease; Pubertal growth; Vitamin D; Weight loss

Indexed keywords

ADALIMUMAB; ALPHA TOCOPHEROL; AZATHIOPRINE; CALCIUM; COLECALCIFEROL; CORTICOSTEROID; FOLIC ACID; GLUCOCORTICOID; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; RECOMBINANT GROWTH FACTOR; RETINOL; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VITAMIN D; ZINC; BIOLOGICAL PRODUCT; GASTROINTESTINAL AGENT; HUMAN GROWTH HORMONE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ALPHA TOCOPHEROL DEFICIENCY; ANOREXIA; BODY HEIGHT; BODY WEIGHT; BONE MASS; CHILD; CHILD GROWTH; CHILD NUTRITION; CLINICAL TRIAL (TOPIC); COLITIS; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DELAYED PUBERTY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; ENTERIC FEEDING; FOLIC ACID DEFICIENCY; FRACTURE; GROWTH ACCELERATION; GROWTH DISORDER; GROWTH RETARDATION; HORMONAL THERAPY; HUMAN; INFLAMMATION; MALABSORPTION; MALNUTRITION; META ANALYSIS (TOPIC); MUCOSAL DISEASE; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; OBESITY; OSSIFICATION; PHYSICAL ACTIVITY; PUBERTY; REMISSION; RETINOL DEFICIENCY; REVIEW; STUNTING; SYSTEMATIC REVIEW (TOPIC); ULCERATIVE COLITIS; UNDERWEIGHT; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY; AGE; BONE DEVELOPMENT; COMPLICATION; FEMALE; GROWTH DISORDERS; MALE; NUTRITIONAL ASSESSMENT; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PUBERTY, DELAYED; RISK FACTOR; TREATMENT OUTCOME; WEIGHT GAIN; YOUNG ADULT;

ADOLESCENT; ADOLESCENT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; AGE FACTORS; BIOLOGICAL PRODUCTS; BODY HEIGHT; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PUBERTY, DELAYED; REMISSION INDUCTION; RISK FACTORS; TREATMENT OUTCOME; WEIGHT GAIN; YOUNG ADULT;

EID: 84910011262     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i37.13219     Document Type: Review

References (71)

1. Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. An update of the role of nutritional therapy in the management of Crohn's disease. J Gastroenterol 2012; 47: 872-882 [PMID: 22699323 DOI: 10.1007/s00535-012-0617-9]
2. Vortia E, Kay M, Wyllie R. The role of growth hormone and insulin-like growth factor-1 in Crohn's disease: implications for therapeutic use of human growth hormone in pediatric patients. Curr Opin Pediatr 2011; 23: 545-551 [PMID: 21900782 DOI: 10.1097/MOP.0b013e32834a7810]
3. Neuman MG, Nanau RM. Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res 2012; 160: 29-44 [PMID: 22687961 DOI: 10.1016/j.trsl.2011.09.001]
4. Haller D. Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism. J Clin Gastroenterol 2010; 44 Suppl 1: S6-S9 [PMID: 20535026 DOI: 10.1097/MCG.0b013e3181dd8b76]
5. Nanau RM, Neuman MG. Metabolome and inflammasome in inflammatory bowel disease. Transl Res 2012; 160: 1-28 [PMID: 22687960 DOI: 10.1016/j.trsl.2011.08.006]
6. Macfarlane S, Steed H, Macfarlane GT. Intestinal bacteria and inflammatory bowel disease. Crit Rev Clin Lab Sci 2009; 46: 25-54 [PMID: 19107650 DOI: 10.1080/10408360802485792]
7. Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res 2012; 56: 524-535 [PMID: 22495981 DOI: 10.1002/mnfr.201100630]
8. Kovács J, Nagy A, Szabó A, Lorincz M. [To grow up with Crohn's disease]. Orv Hetil 2011; 152: 546-554 [PMID: 21436017 DOI: 10.1556/OH2011.29074]
9. Vermeire S, van Assche G, Rutgeerts P. Review article: Altering the natural history of Crohn's disease - evidence for and against current therapies. Aliment Pharmacol Ther 2007; 25: 3-12 [PMID: 17229216]
10. Van Assche G, Vermeire S, Rutgeerts P. The potential for disease modification in Crohn's disease. Nat Rev Gastroenterol Hepatol 2010; 7: 79-85 [PMID: 20134489 DOI: 10.1038/nrgastro.2009.220]
11. Sninsky CA. Altering the natural history of Crohn's disease? Inflamm Bowel Dis 2001; 7 Suppl 1: S34-S39 [PMID: 11380042]
12. Ricart E, García-Bosch O, Ordás I, Panés J. Are we giving biologics too late? The case for early versus late use. World J Gastroenterol 2008; 14: 5523-5527 [PMID: 18810770]
13. Shamir R. Nutritional aspects in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009; 48 Suppl 2: S86-S88 [PMID: 19300135 DOI: 10.1097/MPG.0b013e3181a15ca0]
14. Berni Canani R, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, D'Armiento F, Romeo EF, Cucchiara S. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis 2006; 38: 381-387 [PMID: 16301010]
15. Rubio A, Pigneur B, Garnier-Lengliné H, Talbotec C, Schmitz J, Canioni D, Goulet O, Ruemmele FM. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther 2011; 33: 1332-1339 [PMID: 21507029 DOI: 10.1111/j.1365-2036.2011.04662.x]
16. Heuschkel R. Enteral nutrition should be used to induce remission in childhood Crohn's disease. Dig Dis 2009; 27: 297-305 [PMID: 19786755 DOI: 10.1159/000228564]
17. Day AS, Whitten KE, Sidler M, Lemberg DA. Systematic review: nutritional therapy in paediatric Crohn's disease. Aliment Pharmacol Ther 2008; 27: 293-307 [PMID: 18045244]
18. Shamir R, Phillip M, Levine A. Growth retardation in pediatric Crohn's disease: pathogenesis and interventions. Inflamm Bowel Dis 2007; 13: 620-628 [PMID: 17262806]
19. Heuschkel R, Salvestrini C, Beattie RM, Hildebrand H, Walters T, Griffiths A. Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis 2008; 14: 839-849 [PMID: 18266237 DOI: 10.1002/ibd.20378]
20. Griffiths AM. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently? Dig Dis 2009; 27: 404-411 [PMID: 19786772 DOI: 10.1159/000228581]
21. Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol 2012; 46: 581-589 [PMID: 22772738 DOI: 10.1097/MCG.0b013e318247c32f]
22. Walters TD, Griffiths AM. Growth impairment in pediatric inflammatory bowel disease. Pediatric Inflammatory Bowel Diseases. In: Mamula P, Markowitz JE, Baldassano RN, editors. New York: Springer, 2008: 103-104
23. Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, Merle V, Merlin B, Lerebours E, Savoye G, Salomez JL, Cortot A, Colombel JF, Turck D. Nutritional status and growth in pediatric Crohn's disease: a population-based study. Am J Gastroenterol 2010; 105: 1893-1900 [PMID: 20145606 DOI: 10.1038/ajg.2010.20]
24. Crombé V, Salleron J, Savoye G, Dupas JL, Vernier-Massouille G, Lerebours E, Cortot A, Merle V, Vasseur F, Turck D, Gower-Rousseau C, Lémann M, Colombel JF, Duhamel A. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study. Inflamm Bowel Dis 2011; 17: 2144-2152 [PMID: 21287665 DOI: 10.1002/ibd.21615]
25. Vaisman N, Dotan I, Halack A, Niv E. Malabsorption is a major contributor to underweight in Crohn's disease patients in remission. Nutrition 2006; 22: 855-859 [PMID: 16928471]
26. Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet 2011; 24: 313-326 [PMID: 21564345 DOI: 10.1111/j.1365-277X.2011.01171.x]
27. Soo J, Malik BA, Turner JM, Persad R, Wine E, Siminoski K, Huynh HQ. Use of exclusive enteral nutrition is just as effective as corticosteroids in newly diagnosed pediatric Crohn's disease. Dig Dis Sci 2013; 58: 3584-3591 [PMID: 24026403]
28. Gupta K, Noble A, Kachelries KE, Albenberg L, Kelsen JR, Grossman AB, Baldassano RN. A novel enteral nutrition protocol for the treatment of pediatric Crohn's disease. Inflamm Bowel Dis 2013; 19: 1374-1378 [PMID: 23567777 DOI: 10.1097/MIB.0b013e318281321b]
29. Wiskin AE, Owens DR, Cornelius VR, Wootton SA, Beattie RM. Paediatric nutrition risk scores in clinical practice: children with inflammatory bowel disease. J Hum Nutr Diet 2012; 25: 319-322 [PMID: 22591201 DOI: 10.1111/j.1365-277X.2012.01254.x]
30. Valentini L, Schaper L, Buning C, Hengstermann S, Koernicke T, Tillinger W, Guglielmi FW, Norman K, Buhner S, Ockenga J, Pirlich M, Lochs H. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Nutrition 2008; 24: 694-702 [PMID: 18499398 DOI: 10.1016/j.nut.2008.03.018]
31. Chan SS, Luben R, Olsen A, Tjonneland A, Kaaks R, Teucher B, Lindgren S, Grip O, Key T, Crowe FL, Bergmann MM, Boeing H, Hallmans G, Karling P, Overvad K, Palli D, Masala G, Kennedy H, vanSchaik F, Bueno-de-Mesquita B, Oldenburg B, Khaw KT, Riboli E, Hart AR. Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol 2013; 108: 575-582 [PMID: 23318483 DOI: 10.1038/ajg.2012.453]
32. Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohns Colitis 2012; 6: 665-673 [PMID: 22398103 DOI: 10.1016/j.crohns.2011.11.017]
33. Gerasimidis K, Barclay A, Papangelou A, Missiou D, Buchanan E, Tracey C, Tayler R, Russell RK, Edwards CA, McGrogan P. The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition. Inflamm Bowel Dis 2013; 19: 2411-2422 [PMID: 23899546 DOI: 10.1097/MIB.0b013e31829ed855]
34. Alkhouri RH, Hashmi H, Baker RD, Gelfond D, Baker SS. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013; 56: 89-92 [PMID: 22832510 DOI: 10.1097/MPG.0b013e31826a105d]
35. Vagianos K, Bector S, McConnell J, Bernstein CN. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2007; 31: 311-319 [PMID: 17595441]
36. Kuwabara A, Tanaka K, Tsugawa N, Nakase H, Tsuji H, Shide K, Kamao M, Chiba T, Inagaki N, Okano T, Kido S. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int 2009; 20: 935-942 [PMID: 18825300 DOI: 10.1007/s00198-008-0764-2]
37. Öhlund I, Silfverdal SA, Hernell O, Lind T. Serum 25-hydroxyvitamin D levels in preschool-age children in northern Sweden are inadequate after summer and diminish further during winter. J Pediatr Gastroenterol Nutr 2013; 56: 551-555 [PMID: 23274340 DOI: 10.1097/MPG.0b013e3182838e5b]
38. Carpenter TO, Herreros F, Zhang JH, Ellis BK, Simpson C, Torrealba-Fox E, Kim GJ, Savoye M, Held NA, Cole DE. Demographic, dietary, and biochemical determinants of vitamin D status in inner-city children. Am J Clin Nutr 2012; 95: 137-146 [PMID: 22170368 DOI: 10.3945/ajcn.111.018721]
39. Cranney A, Weiler HA, O'Donnell S, Puil L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 2008; 88: 513S-519S [PMID: 18689393]
40. Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy. Prakut M, Ustun Y, Kabacam G. Serum vitamin B (12) and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 2012; 21: 320-323
41. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007; (158): 1-235 [PMID: 18088161]
42. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22: 142-146 [PMID: 12672710]
43. Yakut M, Ustün Y, Kabac¸am G, Soykan I. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 2010; 21: 320-323 [PMID: 20603044 DOI: 10.1016/j.ejim.2010.05.007]
44. Chowers Y, Sela BA, Holland R, Fidder H, Simoni FB, Bar-Meir S. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol 2000; 95: 3498-3502 [PMID: 11151883]
45. Kim HJ, Hong SJ, Jeon YW, Han JP, Han SH, Kang JH, Tae JW, Lim HS, Kim HK, Ko BM, Lee MS. The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease. Clin Endosc 2013; 46: 71-76 [PMID: 23423611 DOI: 10.5946/ce.2013.46.1.71]
46. Frei P, Fried M, Hungerbuhler V, Rammert C, Rousson V, Kullak-Ublick GA. Analysis of risk factors for low bone mineral density in inflammatory bowel disease. Digestion 2006; 73: 40-46 [PMID: 16543736]
47. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol 2004; 39: 145-153 [PMID: 15000276]
48. van Hogezand RA, Hamdy NA. Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl 2006; (243): 59-64 [PMID: 16782623]
49. Pappa H, Thayu M, Sylvester F, Leonard M, Zemel B, Gordon C. Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011; 53: 11-25 [PMID: 21694532 DOI: 10.1097/MPG.0b013e31821988a3]
50. Pappa HM, Langereis EJ, Grand RJ, Gordon CM. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011; 53: 361-364 [PMID: 21613964 DOI: 10.1097/MPG.0b013e3182250b3e]
51. Schmidt S, Mellström D, Norjavaara E, Sundh V, Saalman R. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012; 55: 511-518 [PMID: 22688562 DOI: 10.1097/MPG.0b013e31825817a0]
52. Irwin R, Lee T, Young VB, Parameswaran N, McCabe LR. Colitis-induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis 2013; 19: 1586-1597 [PMID: 23702805 DOI: 10.1097/MIB.0b013e318289e17b]
53. Tsampalieros A, Lam CK, Spencer JC, Thayu M, Shults J, Zemel BS, Herskovitz RM, Baldassano RN, Leonard MB. Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease. J Clin Endocrinol Metab 2013; 98: 3438-3445 [PMID: 23690309 DOI: 10.1210/jc.2013-1631]
54. Malik S, Ahmed SF, Wilson ML, Shah N, Loganathan S, Naik S, Bourke B, Thomas A, Akobeng AK, Fagbemi A, Wilson DC, Russell RK. The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD). J Crohns Colitis 2012; 6: 337-344 [PMID: 22405171 DOI: 10.1016/j.crohns.2011.09.004]
55. Malik S, Mason A, Bakhshi A, Young D, Bishop J, Garrick V, McGrogan P, Russell RK, Ahmed SF. Growth in children receiving contemporary disease specific therapy for Crohn's disease. Arch Dis Child 2012; 97: 698-703 [PMID: 22685044 DOI: 10.1136/archdischild-2011-300771]
56. Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Viljakainen H, Mäkitie O. Impaired bone health in inflammatory bowel disease: a case-control study in 80 pediatric patients. Calcif Tissue Int 2012; 91: 121-130 [PMID: 22729560 DOI: 10.1007/s00223-012-9617-2]
57. Tsampalieros A, Gupta P, Denburg MR, Shults J, Zemel BS, Mostoufi-Moab S, Wetzsteon RJ, Herskovitz RM, Whitehead KM, Leonard MB. Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res 2013; 28: 480-488 [PMID: 23044926 DOI: 10.1002/jbmr.1785]
58. De Nijs RN. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. Minerva Med 2008; 99: 23-43 [PMID: 18299694]
59. van Brussel MS, Bultink IE, Lems WF. Prevention of glucocorticoid-induced osteoporosis. Expert Opin Pharmacother 2009; 10: 997-1005 [PMID: 19351276 DOI: 10.1517/14656560902868225]
60. Ahmed SF, Horrocks IA, Patterson T, Zaidi S, Ling SC, McGrogan P, Weaver LT. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J Pediatr Gastroenterol Nutr 2004; 38: 276-280 [PMID: 15076625]
61. Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 2004; 19: 1961-1968 [PMID: 15537438]
62. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 1998; 42: 188-194 [PMID: 9536942]
63. Whitten KE, Leach ST, Bohane TD, Woodhead HJ, Day AS. Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease. J Gastroenterol 2010; 45: 399-405 [PMID: 19957194 DOI: 10.1007/s00535-009-0165-0]
64. Kirschner BS, Rich BH. Puberty and pediatric-onset inflammatory bowel disease. Pediatric Inflammatory Bowel Diseases. In: Mamula P, Markowitz JE, Baldassano RN, editors. New York: Springer, 2008: 133-139
65. Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2008; 46: 539-545 [PMID: 18493209 DOI: 10.1097/MPG.0b013e3181596efd]
66. Mason A, Malik S, Russell RK, Bishop J, McGrogan P, Ahmed SF. Impact of inflammatory bowel disease on pubertal growth. Horm Res Paediatr 2011; 76: 293-299 [PMID: 22024935 DOI: 10.1159/000329991]
67. Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease. Nat Rev Gastroenterol Hepatol 2009; 6: 513-523 [PMID: 19713986 DOI: 10.1038/nrgastro.2009.124]
68. D'Mello S, Trauernicht A, Ryan A, Bonkowski E, Willson T, Trapnell BC, Frank SJ, Kugasathan S, Denson LA. Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis. Inflamm Bowel Dis 2012; 18: 236-245 [PMID: 21337672 DOI: 10.1002/ibd.21689]
69. Tietjen K, Behrens R, Weimann E. Growth failure in children and adolescents with Crohn's disease. Turk J Gastroenterol 2009; 20: 13-19 [PMID: 19330730]
70. Wong SC, Hassan K, McGrogan P, Weaver LT, Ahmed SF. The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature. J Pediatr Endocrinol Metab 2007; 20: 1315-1324 [PMID: 18341091]
71. Wong SC, Kumar P, Galloway PJ, Blair JC, Didi M, Dalzell AM, Hassan K, McGrogan P, Ahmed SF. A preliminary trial of the effect of recombinant human growth hormone on short-term linear growth and glucose homeostasis in children with Crohn's disease. Clin Endocrinol (Oxf) 2011; 74: 599-607 [PMID: 21470283 DOI: 10.1111/j.1365-2265.2011.03977]